UnknownPhase 2ketamine

Ketamine and Glutamate After Brain Injury : a Microdialysis Study

Sponsored by Pierre-Julien CUNGI

NCT ID
NCT02232347
Target Enrollment
20 participants
Start Date
2014-10
Est. Completion
2017-05

About This Study

The objective of the study is to compare the effects of 48 hours ketamine infusion versus sufentanil infusion on brain glutamate concentrations measured with microdialysis after traumatic brain injury. We hypothesize that ketamine infusion will decrease high glutamate values faster than sufentanil.

Conditions Studied

Head Trauma

Interventions

  • Ketamine
  • Sufentanil

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* \> 18 years old
* Glasgow Coma Scale (GCS) \< 9
* \> 3 days of sedation expected at the arrival

Exclusion Criteria:

* pregnancy
* \< 18 years old
* estimated survival \< 48 hours post-trauma
* expected sedation \< 3 days
* coagulation impairment (platelets\<100.000/mm3 and prothrombin time (TP) \<60%)
* Cardiac arrest before ICU admission
* Admission \> 12 hours after trauma
* Multimodal monitoring implanted \> 24 hours post trauma
* Participation to the study refused by the next of kind
* No next of kind

Study Locations (1)

Sainte Anne Military Teaching Hospital
Toulon, France

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source